Bayer chief executive Bill Anderson has said that newer product launches have offset the decline in sales of anticoagulant ...

Earlier this April, Aurobindo had also received USFDA approval for the manufacture and marketing of Rivaroxaban Tablets USP, 2.5mg, a generic equivalent of Xarelto 2.5mg of Janssen Pharmaceuticals.

Xarelto (rivaroxaban) is the first of the NOACs to ... and found that compared to patients treated with Bayer and Janssen's drug had a similar risk of stroke or transient ischaemic attack ...

Dr Reddy's has denied the workforce reduction claims. "We categorically deny the claim of a 25% workforce cost reduction and the other claims mentioned in the said news article," the company said.

Payers and providers, often depicted as rivals, are on the same side when it comes to the 340B program that allows some ...

The said drug is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), XARELTO, 2.5 mg of Janssen Pharmaceuticals Inc. Rivaroxaban Tablet USP is used to reduce the risk of ...

to make and sell Rivaroxaban Tablets USP, 2.5mg — the generic equivalent of Janssen Pharmaceuticals’s blockbuster drug, Xarelto 2.5mg. NHPC NHPC has commenced commercial operations of 107.14 ...

which is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), XARELTO, 2.5 mg of Janssen Pharmaceuticals Inc. Rivaroxaban Tablet USP is used (i) to reduce the risk of ...

for the production and sale of Rivaroxaban Tablets USP, 2.5mg. This drug is the generic equivalent of Janssen Pharmaceuticals' blockbuster medication, Xarelto 2.5mg. NHPC Limited has commenced ...